Loading…

Selected pharmacodynamic and biochemical properties of selenonium choline

1. 1. Five minutes after intravenous administration of 50 mg/kg of the novel choline analogue selenonium choline [(CH 3) 2Se +CH 2CH 2OH, SeCh], only 8% of the administered dose was accounted for in blood, brain, liver, heart, and kidney tissues. 2. 2. SeCh was acetylated in vivo to acetylselenonium...

Full description

Saved in:
Bibliographic Details
Published in:General pharmacology 1998, Vol.30 (1), p.95-101
Main Authors: Khatri, J.N., Silks, L.A., Kosh, J.W.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c337t-2da90ce0045bf6e2494a6781798f323d868d1eeb41df1e76f9201940eb9066703
container_end_page 101
container_issue 1
container_start_page 95
container_title General pharmacology
container_volume 30
creator Khatri, J.N.
Silks, L.A.
Kosh, J.W.
description 1. 1. Five minutes after intravenous administration of 50 mg/kg of the novel choline analogue selenonium choline [(CH 3) 2Se +CH 2CH 2OH, SeCh], only 8% of the administered dose was accounted for in blood, brain, liver, heart, and kidney tissues. 2. 2. SeCh was acetylated in vivo to acetylselenonium choline (ASeCh) in all of the tissues examined. 3. 3. During postmortem incubation, brain concentrations of SeCh and ASeCh increased to 535% and to 425%, respectively. 4. 4. K m and V max values for the phosphorylation of SeCh by choline kinase were higher and lower, respectively, compared to the phosphorylation of choline. 5. 5. Acetylation of SeCh was described with K m and V max values that were both higher than the values for Ch. 6. 6. The data suggest that SeCh is phosphorylated and incorporated into various lipids in brain tissue, and is acetylated to ASeCh by both nonneural and neural tissues.
doi_str_mv 10.1016/S0306-3623(97)00080-3
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79681152</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0306362397000803</els_id><sourcerecordid>79681152</sourcerecordid><originalsourceid>FETCH-LOGICAL-c337t-2da90ce0045bf6e2494a6781798f323d868d1eeb41df1e76f9201940eb9066703</originalsourceid><addsrcrecordid>eNqFkE1LJDEQhsPiouO4P0Hog8h6aLeSdOfjJCJ-wcAeXM8hnVQzke7OmMwI8-83OsNcPRVFPW9V8RByTuGaAhV_XoCDqLlg_LeWVwCgoOY_yIwqqWsASo_I7ICckNOc3wrEWsaOybFuWtkoNSPPLzigW6OvVkubRuui3052DK6yk6-6EN0SS2eHapXiCtM6YK5iX-USm-IUNmPllnEIE56Rn70dMv7a1zl5fbj_d_dUL_4-Pt_dLmrHuVzXzFsNDgGatusFskY3VkhFpVY9Z9wroTxF7Brqe4pS9JoB1Q1gp0EICXxOLnd7y0PvG8xrM4bscBjshHGTjdRCUdqyArY70KWYc8LerFIYbdoaCuZToflSaD79GC3Nl0LDS-58f2DTjegPqb2zMr_Yz20uYvpkJxfyAWOUSa6agt3sMCwyPgImk13AyaEPqRg3PoZvHvkPdpKM2Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79681152</pqid></control><display><type>article</type><title>Selected pharmacodynamic and biochemical properties of selenonium choline</title><source>ScienceDirect Freedom Collection</source><creator>Khatri, J.N. ; Silks, L.A. ; Kosh, J.W.</creator><creatorcontrib>Khatri, J.N. ; Silks, L.A. ; Kosh, J.W.</creatorcontrib><description>1. 1. Five minutes after intravenous administration of 50 mg/kg of the novel choline analogue selenonium choline [(CH 3) 2Se +CH 2CH 2OH, SeCh], only 8% of the administered dose was accounted for in blood, brain, liver, heart, and kidney tissues. 2. 2. SeCh was acetylated in vivo to acetylselenonium choline (ASeCh) in all of the tissues examined. 3. 3. During postmortem incubation, brain concentrations of SeCh and ASeCh increased to 535% and to 425%, respectively. 4. 4. K m and V max values for the phosphorylation of SeCh by choline kinase were higher and lower, respectively, compared to the phosphorylation of choline. 5. 5. Acetylation of SeCh was described with K m and V max values that were both higher than the values for Ch. 6. 6. The data suggest that SeCh is phosphorylated and incorporated into various lipids in brain tissue, and is acetylated to ASeCh by both nonneural and neural tissues.</description><identifier>ISSN: 0306-3623</identifier><identifier>EISSN: 1879-0011</identifier><identifier>DOI: 10.1016/S0306-3623(97)00080-3</identifier><identifier>PMID: 9457488</identifier><identifier>CODEN: GEPHDP</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Acetylation ; Animals ; Biochemistry and metabolism ; Biological and medical sciences ; Brain - metabolism ; Central nervous system ; Choline - analogs &amp; derivatives ; Choline - metabolism ; Choline - pharmacokinetics ; cholinergic ; false neurotransmitter ; Fundamental and applied biological sciences. Psychology ; Male ; Mice ; Mice, Inbred ICR ; Phosphorylation ; postmortem ; Selenium ; Selenium - metabolism ; Selenium - pharmacokinetics ; selenonium choline ; Tissue Distribution ; Vertebrates: nervous system and sense organs</subject><ispartof>General pharmacology, 1998, Vol.30 (1), p.95-101</ispartof><rights>1998</rights><rights>1998 INIST-CNRS</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c337t-2da90ce0045bf6e2494a6781798f323d868d1eeb41df1e76f9201940eb9066703</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010,27900,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2127384$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9457488$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Khatri, J.N.</creatorcontrib><creatorcontrib>Silks, L.A.</creatorcontrib><creatorcontrib>Kosh, J.W.</creatorcontrib><title>Selected pharmacodynamic and biochemical properties of selenonium choline</title><title>General pharmacology</title><addtitle>Gen Pharmacol</addtitle><description>1. 1. Five minutes after intravenous administration of 50 mg/kg of the novel choline analogue selenonium choline [(CH 3) 2Se +CH 2CH 2OH, SeCh], only 8% of the administered dose was accounted for in blood, brain, liver, heart, and kidney tissues. 2. 2. SeCh was acetylated in vivo to acetylselenonium choline (ASeCh) in all of the tissues examined. 3. 3. During postmortem incubation, brain concentrations of SeCh and ASeCh increased to 535% and to 425%, respectively. 4. 4. K m and V max values for the phosphorylation of SeCh by choline kinase were higher and lower, respectively, compared to the phosphorylation of choline. 5. 5. Acetylation of SeCh was described with K m and V max values that were both higher than the values for Ch. 6. 6. The data suggest that SeCh is phosphorylated and incorporated into various lipids in brain tissue, and is acetylated to ASeCh by both nonneural and neural tissues.</description><subject>Acetylation</subject><subject>Animals</subject><subject>Biochemistry and metabolism</subject><subject>Biological and medical sciences</subject><subject>Brain - metabolism</subject><subject>Central nervous system</subject><subject>Choline - analogs &amp; derivatives</subject><subject>Choline - metabolism</subject><subject>Choline - pharmacokinetics</subject><subject>cholinergic</subject><subject>false neurotransmitter</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred ICR</subject><subject>Phosphorylation</subject><subject>postmortem</subject><subject>Selenium</subject><subject>Selenium - metabolism</subject><subject>Selenium - pharmacokinetics</subject><subject>selenonium choline</subject><subject>Tissue Distribution</subject><subject>Vertebrates: nervous system and sense organs</subject><issn>0306-3623</issn><issn>1879-0011</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNqFkE1LJDEQhsPiouO4P0Hog8h6aLeSdOfjJCJ-wcAeXM8hnVQzke7OmMwI8-83OsNcPRVFPW9V8RByTuGaAhV_XoCDqLlg_LeWVwCgoOY_yIwqqWsASo_I7ICckNOc3wrEWsaOybFuWtkoNSPPLzigW6OvVkubRuui3052DK6yk6-6EN0SS2eHapXiCtM6YK5iX-USm-IUNmPllnEIE56Rn70dMv7a1zl5fbj_d_dUL_4-Pt_dLmrHuVzXzFsNDgGatusFskY3VkhFpVY9Z9wroTxF7Brqe4pS9JoB1Q1gp0EICXxOLnd7y0PvG8xrM4bscBjshHGTjdRCUdqyArY70KWYc8LerFIYbdoaCuZToflSaD79GC3Nl0LDS-58f2DTjegPqb2zMr_Yz20uYvpkJxfyAWOUSa6agt3sMCwyPgImk13AyaEPqRg3PoZvHvkPdpKM2Q</recordid><startdate>1998</startdate><enddate>1998</enddate><creator>Khatri, J.N.</creator><creator>Silks, L.A.</creator><creator>Kosh, J.W.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1998</creationdate><title>Selected pharmacodynamic and biochemical properties of selenonium choline</title><author>Khatri, J.N. ; Silks, L.A. ; Kosh, J.W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c337t-2da90ce0045bf6e2494a6781798f323d868d1eeb41df1e76f9201940eb9066703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Acetylation</topic><topic>Animals</topic><topic>Biochemistry and metabolism</topic><topic>Biological and medical sciences</topic><topic>Brain - metabolism</topic><topic>Central nervous system</topic><topic>Choline - analogs &amp; derivatives</topic><topic>Choline - metabolism</topic><topic>Choline - pharmacokinetics</topic><topic>cholinergic</topic><topic>false neurotransmitter</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred ICR</topic><topic>Phosphorylation</topic><topic>postmortem</topic><topic>Selenium</topic><topic>Selenium - metabolism</topic><topic>Selenium - pharmacokinetics</topic><topic>selenonium choline</topic><topic>Tissue Distribution</topic><topic>Vertebrates: nervous system and sense organs</topic><toplevel>online_resources</toplevel><creatorcontrib>Khatri, J.N.</creatorcontrib><creatorcontrib>Silks, L.A.</creatorcontrib><creatorcontrib>Kosh, J.W.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>General pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Khatri, J.N.</au><au>Silks, L.A.</au><au>Kosh, J.W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Selected pharmacodynamic and biochemical properties of selenonium choline</atitle><jtitle>General pharmacology</jtitle><addtitle>Gen Pharmacol</addtitle><date>1998</date><risdate>1998</risdate><volume>30</volume><issue>1</issue><spage>95</spage><epage>101</epage><pages>95-101</pages><issn>0306-3623</issn><eissn>1879-0011</eissn><coden>GEPHDP</coden><abstract>1. 1. Five minutes after intravenous administration of 50 mg/kg of the novel choline analogue selenonium choline [(CH 3) 2Se +CH 2CH 2OH, SeCh], only 8% of the administered dose was accounted for in blood, brain, liver, heart, and kidney tissues. 2. 2. SeCh was acetylated in vivo to acetylselenonium choline (ASeCh) in all of the tissues examined. 3. 3. During postmortem incubation, brain concentrations of SeCh and ASeCh increased to 535% and to 425%, respectively. 4. 4. K m and V max values for the phosphorylation of SeCh by choline kinase were higher and lower, respectively, compared to the phosphorylation of choline. 5. 5. Acetylation of SeCh was described with K m and V max values that were both higher than the values for Ch. 6. 6. The data suggest that SeCh is phosphorylated and incorporated into various lipids in brain tissue, and is acetylated to ASeCh by both nonneural and neural tissues.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>9457488</pmid><doi>10.1016/S0306-3623(97)00080-3</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0306-3623
ispartof General pharmacology, 1998, Vol.30 (1), p.95-101
issn 0306-3623
1879-0011
language eng
recordid cdi_proquest_miscellaneous_79681152
source ScienceDirect Freedom Collection
subjects Acetylation
Animals
Biochemistry and metabolism
Biological and medical sciences
Brain - metabolism
Central nervous system
Choline - analogs & derivatives
Choline - metabolism
Choline - pharmacokinetics
cholinergic
false neurotransmitter
Fundamental and applied biological sciences. Psychology
Male
Mice
Mice, Inbred ICR
Phosphorylation
postmortem
Selenium
Selenium - metabolism
Selenium - pharmacokinetics
selenonium choline
Tissue Distribution
Vertebrates: nervous system and sense organs
title Selected pharmacodynamic and biochemical properties of selenonium choline
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T12%3A39%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Selected%20pharmacodynamic%20and%20biochemical%20properties%20of%20selenonium%20choline&rft.jtitle=General%20pharmacology&rft.au=Khatri,%20J.N.&rft.date=1998&rft.volume=30&rft.issue=1&rft.spage=95&rft.epage=101&rft.pages=95-101&rft.issn=0306-3623&rft.eissn=1879-0011&rft.coden=GEPHDP&rft_id=info:doi/10.1016/S0306-3623(97)00080-3&rft_dat=%3Cproquest_cross%3E79681152%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c337t-2da90ce0045bf6e2494a6781798f323d868d1eeb41df1e76f9201940eb9066703%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=79681152&rft_id=info:pmid/9457488&rfr_iscdi=true